Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 3Uterine Neoplasms 1Stomach Neoplasms 1Sarcoma 1Pleural Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Mediastinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Appendiceal Neoplasms 1

Interventions

Gemcitabine 9Docetaxel 5Mitomycin 4erdafitinib 3durvalumab 3Cystoscopy 3disitamab vedotin 2BCG Vaccine 25-aminolevulinic acid hexyl ester 2tremelimumab 1tislelizumab 1monalizumab 1dodecyl maltoside 1chondroitin sulfate, sodium hyaluronate drug combination 1bicalutamide 1Urine Specimen Collection 1Transurethral Resection of Bladder 1Therapeutic Uses 1Surveys and Questionnaires 1Saline Solution 1Patient Discharge 1Paclitaxel 1Nonsteroidal Anti-Androgens 1Monatide (IMS 3015) 1Mitozytrex 1Metformin 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Hyaluronic Acid 1House Calls 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Non-Muscle Invasive Bladder Neoplasms × Mitozytrex × Clear all
NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Mayo Clinic

Phase 1/2 Recruiting
40 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡